InvestorsHub Logo
Followers 5
Posts 484
Boards Moderated 0
Alias Born 11/21/2019

Re: None

Friday, 08/28/2020 7:51:01 PM

Friday, August 28, 2020 7:51:01 PM

Post# of 16704
Algernon to Provide Update on its Ifenprodil IPF and Chronic Cough Phase 2 Human Study Featured on BioPub Webcast Hosted by Dr. KSS MD PhD
Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical development company, is pleased to announce that it will be prov




https://finance.yahoo.com/news/algernon-ifenprodil-ipf-chronic-cough-120000712.html